These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7923826)

  • 61. No mutation in the KCNE3 potassium channel gene in Chinese thyrotoxic hypokalaemic periodic paralysis patients.
    Tang NL; Chow CC; Ko GT; Tai MH; Kwok R; Yao XQ; Cockram CS
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):109-12. PubMed ID: 15212652
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [A case of periodic thyrotoxic paralysis].
    Kisoka G; Bertrand X
    Rev Med Liege; 2019 Jan; 74(1):20-22. PubMed ID: 30680969
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of the literature.
    Ober KP
    Medicine (Baltimore); 1992 May; 71(3):109-20. PubMed ID: 1635436
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thyrotoxic periodic paralysis: diversity in America.
    Patel H; Wilches LV; Guerrero J
    J Emerg Med; 2014 Jun; 46(6):760-2. PubMed ID: 24315723
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical features and recovery patterns of acquired non-thyrotoxic hypokalemic paralysis.
    Hiraga A; Kamitsukasa I; Kojima K; Kuwabara S
    J Neurol Sci; 2012 Feb; 313(1-2):42-5. PubMed ID: 22000401
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Platelet Na+, K+-ATPase activity as a possible peripheral marker for the neurotoxic effects of phenylalanine in phenylketonuria.
    Bedin M; Estrella CH; Duarte DV; Ponzi D; Dutra-Filho CS; Wyse AT; Wajner M; Wannmacher CM
    Metab Brain Dis; 2000 Jun; 15(2):115-21. PubMed ID: 11092578
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Thyrotoxic periodic paralysis: a case report].
    Vale J; Canas N; Leal A; Vilar H
    Acta Med Port; 2005; 18(5):399-402. PubMed ID: 16611545
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Thyrotoxic periodic paralysis in a Chinese population.
    Ko GT; Chow CC; Yeung VT; Chan HH; Li JK; Cockram CS
    QJM; 1996 Jun; 89(6):463-8. PubMed ID: 8758050
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A circulating inhibitor of the platelet Na+,K+ adenosine triphosphatase (ATPase) enzyme in allergy.
    Skoner DP; Gentile D; Evans RW
    J Allergy Clin Immunol; 1991 Feb; 87(2):476-82. PubMed ID: 1847156
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Animal and human tissue Na,K-ATPase in obesity and diabetes: A new proposed enzyme regulation.
    Iannello S; Milazzo P; Belfiore F
    Am J Med Sci; 2007 Jan; 333(1):1-9. PubMed ID: 17220688
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Renal Na-K-ATPase hyperactivity in diabetic Psammomys obesus is related to glomerular hyperfiltration but is insulin-independent.
    Scherzer P; Nachliel I; Bar-On H; Popovtzer MM; Ziv E
    J Endocrinol; 2000 Nov; 167(2):347-54. PubMed ID: 11054650
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis.
    Lin SH; Lin YF
    Am J Kidney Dis; 2001 Mar; 37(3):620-3. PubMed ID: 11228188
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Artificial Intelligence-Assisted Electrocardiography for Early Diagnosis of Thyrotoxic Periodic Paralysis.
    Lin C; Lin CS; Lee DJ; Lee CC; Chen SJ; Tsai SH; Kuo FC; Chau T; Lin SH
    J Endocr Soc; 2021 Sep; 5(9):bvab120. PubMed ID: 34308091
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Regression of renal hypertrophy and elevated renal Na+,K+-ATPase activity after insulin treatment in streptozotocin-diabetic rats.
    Ku DD; Roberts RB; Sellers BM; Meezan E
    Endocrinology; 1987 May; 120(5):2166-73. PubMed ID: 3032576
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An atypical presentation of high potassium renal secretion rate in a patient with thyrotoxic periodic paralysis: a case report.
    Tu ML; Fang YW; Leu JG; Tsai MH
    BMC Nephrol; 2018 Jul; 19(1):160. PubMed ID: 29973184
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The involvement of Na+/K(+)-ATPase in the development of platelet procoagulant response.
    Tomasiak M; Stelmach H; Rusak T; Ciborowski M; Radziwon P
    Acta Biochim Pol; 2007; 54(3):625-39. PubMed ID: 17653302
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Manifestation of thyrotoxic periodic paralysis in two patients with adrenal adenomas and hyperandrogenaemia.
    Biering H; Bauditz J; Pirlich M; Lochs H; Gerl H
    Horm Res; 2003; 59(6):301-4. PubMed ID: 12784096
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Thyrotoxic periodic paralysis. A report of 2 cases].
    Carod-Artal FJ; Delgado-Villora R
    Rev Neurol; 1999 Sep 16-30; 29(6):510-2. PubMed ID: 10584263
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Glucose intolerance in thyrotoxicosis roles of insulin, glucagon and somatostatin.
    Lam KS; Yeung RT; Ho PW; Lam SK
    Acta Endocrinol (Copenh); 1987 Feb; 114(2):228-34. PubMed ID: 2881418
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vitro modulation of platelet sodium, potassium adenosine triphosphatase enzyme activity by antiallergy drugs.
    Gentile DA; Brown C; Skoner DP
    J Lab Clin Med; 1993 Jul; 122(1):85-91. PubMed ID: 8391560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.